AAKP has recorded their November HealthLine webinar, variously named as Are You at Risk for Secondary Hyperparathyroidism? Learn the Importance of Early Detection, and The Pathogenesis and Treatment of CKD-MBD. CKD-related Mineral Bone Disease, in this case Hypocalcemia, can cause excessive secretion of parathyroid hormone (PTH) or Secondary Hyperparathyroidism. Tune into the webinar recording at https://www.gotostage.com/channel/6927452477730326277/recording/9cfd79d963c345628f3e38d8ba44a5ab/watch, or read more about it at https://aakp.org/blog/aakp-healthline-webinar-summary-risk-secondary-hyperparathyroidism-learn-importance-early-detection/.
ANNA Chapter 503 will hold evening Meet & Greet meetings in Portland OR on November 7, 2018 and in Chehalis WA November 8, 2018, providing opportunities to meet your ANNA 503 Chapter Officers and Education Planning Committee, and local Nephrology Colleagues. Registration is required by noon on November 7 (tomorrow), but a $5 donation will buy you dinner during the scheduled talk on The Role of Parsabiv in the Treatment of Secondary Hyperparathyroidism (HPT) in Adult Patients on Hemodialysis. For all the details see:
- https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/ANNA/ANNA110718.pdf for Portland on November 7
- https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/ANNA/ANNA110818.pdf for Chehalis on November 8
We apologize for the short notice.
CMS has discovered that the data file used to calculate PY2019 ESRD QIP Performance Scores omitted data on PD patients, which resulted in inaccurate Mineral Metabolism, Hypercalcemia, and Total Performance Scores for about one-third of eligible facilities. A complete list of impacted facilities can be found at https://www.qualitynet.org/dcs/BlobServer?blobkey=id&blobnocache=true&blobwhere=1228890843976&blobheader=multipart%2Foctet-stream&blobheadername1=Content-Disposition&blobheadervalue1=attachment%3Bfilename%3DESRD_QIP_PY19_AffctdDlysFclts.pdf&blobcol=urldata&blobtable=MungoBlobs.
CMS has recalculated PY2019 Performance Score results. Corrected PSRs and Patient List Reports will be released on or before August 24, 2018. While only impacted facilities will see a change in their reports, all facilities will receive new reports. In order to provide facilities with sufficient time to review their revised reports, CMS has extended the QIP Preview Period till September 19, 2018 at 11:59 PM PDT. Try to submit your Clarification Questions by early September, so CMS has time to respond and you have time before the deadline to submit your Formal Inquiry, if necessary.
For further assistance regarding the QIP Preview, please contact the ESRD QIP Support Team using the ESRD QIP Q&A Tool at https://cms-ocsq.custhelp.com/app/homeesrdqip/p/960. If you have questions or concerns regarding use of the ESRD QIP system, please contact the QualityNet Help Desk at firstname.lastname@example.org or 866-288-8912 between 5 am and 5 pm PDT Monday through Friday.
CMS has released the proposed ESRD QIP Technical Specifications for PY2021, 2022, and 2024. Proposed changes include:
- Elimination of Pain Assessment (NOT Depression Screening as indicated earlier), NHSN Healthcare Personnel Vaccination, Anemia Management, and Serum Phosphorous in PY2021.
- New measures for Medication Reconciliation Reporting and Existing-Patient Transplant Waitlist for PY2022.
- A new measure for Incident-Patient Transplant Waitlist in PY2024.
CMS has released a proposed rule for the CY2019 ESRD PPS, titled Proposed Updates to Policies and Payment Rates for the ESRD PPS, … QIP; and Payment for Renal Dialysis Services Furnished to Individuals with AKI and a fact sheet summarizing it. The ellipsis in the title refers to durable medical equipment changes included in the same proposed rule. Find the fact sheet at https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2018-Fact-sheets-items/2018-07-11.html.
The fact sheet includes summaries of:
- Removing the Healthcare Personnel Vaccination, Pain Assessment, Anemia Management, and Serum Phosphorus reporting measures from the PY2021 QIP.
- Restructuring domains and weights in the PY2021 QIP.
- Expanding NHSN validation in both PY2021 and PY2022.
- Adding measures for Percentage of Patients Waitlisted and Medication Reconciliation to the PY2022 QIP.
- Adding a measure on Standardized First Transplant Waitlist Ratio for Incident Patients to the PY2024 QIP.
The proposed rule can be found on the Federal Register at https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-14986.pdf. Comments must be received by September 10, 2018.
The American Kidney Fund will present a free June 22, 2018 webinar on Phosphorus in the Kidney Disease Diet. The webinar is open to everyone, including patients, family, friends, and professionals. For details and registration, see http://www.kidneyfund.org/training/webinars/phosphorus-in-the-kidney.html.
CMS has announced that new data on the care quality of dialysis facilities is now available on Dialysis Facility Compare (DFC), the website that allows patients and health centers to view and compare quality data about dialysis facilities. CMS uses this data, organized into a series of measures, to create a 5-Star Rating system that can help patients make educated decisions about where to get their dialysis treatments, as well as to assist them in speaking with their healthcare team regarding their care.
The January revision has updated information for Standardized Transfusion Ratios, Standardized Mortality Ratios, Standardized Hospitalization Ratios, Standardized Readmission Ratios, vascular access types (fistula and catheter), bloodstream infections, hemoglobin management, and the CAHPS survey on in-center hemodialysis patient experience. The July 2017 DFC data for dialysis adequacy, hypercalcemia, serum phosphorus, and the facility Star Ratings will remain until the next update.
Find DFC at https://www.medicare.gov/dialysisfacilitycompare/#.
If you’re computer-savvy, you can download supplementary DFC data from https://data.medicare.gov/data/dialysis-facility-compare.